News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
TUNG YANG GUANG PHARMACEUTICAL (06887.HK) Showcases Three Innovative Drugs at 2026 AACR Annual Meeting
TUNG YANG GUANG PHARMACEUTICAL (06887.HK) announced that at the 2026 American Association for Cancer Research (AACR) Annual Meeting held from April 17 to 22 in San Diego, Californi...
Reset
Send
The window will close in 5 seconds
TUNG YANG GUANG PHARMACEUTICAL (06887.HK) Showcases Three Innovative Drugs at 2026 AACR Annual Meeting
Close
Recommend
4
Positive
2
Negative
0
 
 

TUNG YANG GUANG PHARMACEUTICAL (06887.HK)  0.000 (0.000%)    Short selling $5.58M; Ratio 38.989%   announced that at the 2026 American Association for Cancer Research (AACR) Annual Meeting held from April 17 to 22 in San Diego, California, the United States, the group presented the latest preclinical research results of three oncology pipeline candidates in the form of three poster presentations. The projects cover a CDH17/4-1BB bispecific antibody, an oral highly active Pan-RAS molecular glue inhibitor, and an oral small-molecule PD-L1 inhibitor. (de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-01 16:25.)

Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.